467 related articles for article (PubMed ID: 28696220)
1. Prevention of Sudden Cardiac Death in Adults With Congenital Heart Disease: Do the Guidelines Fall Short?
Vehmeijer JT; Koyak Z; Budts W; Harris L; Silversides CK; Oechslin EN; Bouma BJ; Zwinderman AH; Mulder BJM; de Groot JR
Circ Arrhythm Electrophysiol; 2017 Jul; 10(7):. PubMed ID: 28696220
[TBL] [Abstract][Full Text] [Related]
2. Current state of risk stratification for sudden cardiac death in adults with congenital heart disease.
Vehmeijer JT; Mulder BJ; de Groot JR
Anatol J Cardiol; 2018 Jun; 19(6):401-403. PubMed ID: 29537971
[TBL] [Abstract][Full Text] [Related]
3. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD).
Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR
Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.
Santharam S; Hudsmith L; Thorne S; Clift P; Marshall H; De Bono J
Europace; 2017 Mar; 19(3):407-413. PubMed ID: 27234868
[TBL] [Abstract][Full Text] [Related]
5. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410
[TBL] [Abstract][Full Text] [Related]
6. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
[TBL] [Abstract][Full Text] [Related]
7. Predicting therapies in Japanese hypertrophic cardiomyopathy patients with an implantable cardioverter-defibrillator using the 2014 European Society of Cardiology guidelines.
Nakano M; Kondo Y; Nakano M; Kajiyama T; Miyazawa K; Hayashi T; Ito R; Takahira H; Kobayashi Y
Heart Vessels; 2021 Jan; 36(1):99-104. PubMed ID: 32666207
[TBL] [Abstract][Full Text] [Related]
8. Prolonged T
Vehmeijer JT; Koyak Z; Vink AS; Budts W; Harris L; Silversides CK; Oechslin EN; Zwinderman AH; Mulder BJM; de Groot JR
Congenit Heart Dis; 2019 Nov; 14(6):952-957. PubMed ID: 31573144
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of adult patients with congenital heart disease and an implantable cardioverter defibrillator.
Coutinho Cruz M; Viveiros Monteiro A; Portugal G; Laranjo S; Lousinha A; Valente B; Osório P; Silva Cunha P; de Sousa L; Oliveira JA; Agapito A; Martins Oliveira M; Pinto F; Cruz Ferreira R
Congenit Heart Dis; 2019 Jul; 14(4):525-533. PubMed ID: 30889316
[TBL] [Abstract][Full Text] [Related]
10. Lesion-specific differences for implantable cardioverter defibrillator therapies in adults with congenital heart disease.
Kella DK; Merchant FM; Veledar E; Book W; Lloyd MS
Pacing Clin Electrophysiol; 2014 Nov; 37(11):1492-8. PubMed ID: 24889130
[TBL] [Abstract][Full Text] [Related]
11. Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: What has Changed in The Guidelines?
Reis L; Teixeira R; Fernandes A; Almeida I; Madeira M; Silva J; Botelho A; Pais J; Nascimento J; Gonçalves L
Arq Bras Cardiol; 2018 Jun; 110(6):524-531. PubMed ID: 30226910
[TBL] [Abstract][Full Text] [Related]
12. Sudden cardiac death in adults with congenital heart disease: does QRS-complex fragmentation discriminate in structurally abnormal hearts?
Vehmeijer JT; Koyak Z; Bokma JP; Budts W; Harris L; Mulder BJM; de Groot JR
Europace; 2018 Jun; 20(FI1):f122-f128. PubMed ID: 28402450
[TBL] [Abstract][Full Text] [Related]
13. Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis.
Vehmeijer JT; Brouwer TF; Limpens J; Knops RE; Bouma BJ; Mulder BJ; de Groot JR
Eur Heart J; 2016 May; 37(18):1439-48. PubMed ID: 26873095
[TBL] [Abstract][Full Text] [Related]
14. Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease.
Wang L; Javadekar N; Rajagopalan A; Rogovoy NM; Haq KT; Broberg CS; Tereshchenko LG
Heart Rhythm; 2020 May; 17(5 Pt B):860-869. PubMed ID: 32354451
[TBL] [Abstract][Full Text] [Related]
15. Defibrillators in adult congenital heart disease: Long-term risk of appropriate shocks, inappropriate shocks, and complications.
Moore BM; Cao J; Cordina RL; McGuire MA; Celermajer DS
Pacing Clin Electrophysiol; 2020 Jul; 43(7):746-753. PubMed ID: 32495949
[TBL] [Abstract][Full Text] [Related]
16. PREVENTION-ACHD: PRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease; Rationale and Design.
Vehmeijer JT; Koyak Z; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Silversides CK; Bouma BJ; Budts W; van Gelder IC; Oliver JM; Mulder BJM; de Groot JR
Neth Heart J; 2019 Oct; 27(10):474-479. PubMed ID: 31270738
[TBL] [Abstract][Full Text] [Related]
17. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
[TBL] [Abstract][Full Text] [Related]
18. Can we predict sudden cardiac death in long-term survivors of atrial switch surgery for transposition of the great arteries?
Wheeler M; Grigg L; Zentner D
Congenit Heart Dis; 2014; 9(4):326-32. PubMed ID: 24151816
[TBL] [Abstract][Full Text] [Related]
19. Eligibility for subcutaneous implantable cardioverter-defibrillator in adults with congenital heart disease.
Zormpas C; Silber-Peest AS; Eiringhaus J; Hillmann HAK; Hohmann S; Müller-Leisse J; Westhoff-Bleck M; Veltmann C; Duncker D
ESC Heart Fail; 2021 Apr; 8(2):1502-1508. PubMed ID: 33538124
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: implications of international guidelines.
Foley PW; Addison CE; Whinney SB; Patel K; Cunningham D; Frenneaux MP; Leyva F
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S131-4. PubMed ID: 19250076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
